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ABSTRACT The relative contributions of
the allosteric and affinity factors toward
the change in p50 have been calcu-
lated for a series of effectors of hemo-
globin (Hb). Shifts in the ligand affinity
of deoxy Hb and the values for 50%
ligand saturation (p50) were obtained
from oxygen equilibrium data. Because
the high-affinity parameters (liganded
conformation) are poorly determined
from the equilibrium curves, they were
determined from kinetic measurements
of the association and dissociation
rates with CO as ligand. The CO on-
rates were obtained by flash photolysis
measurements. The off-rates were
determined from the rate of oxidation
of HbCO by ferricyanide, or by replace-
ment of CO with NO. The partition
function of fully liganded hemoglobin
for oxygen and CO is only slightly
changed by the effectors.
Measurements were made in the
presence of the effectors 2,3-diphos-
phoglycerate (DPG), inositol hexakis-
phosphate (IHP), bezafibrate (Bzf), and
two recently synthesized derivatives of
Bzf (LR 16 and L35). Values of p50
change by over a factor of 60; the
on-rates decrease by nearly a factor of
8, with little change in the off-rates for
the liganded conformation. The data
indicate that both allosteric and affinity
parameters are changed by the effec-
tors; the changes in ligand affinity rep-
resent the larger contribution toward
shifts in p50.
INTRODUCTION
The characterization of hemoglobin (Hb) requires the
separation of the different states in equilibrium. Hb can
bind four ligands such as oxygen or CO, but does so with
at least two different affinities. Two allosteric forms,
called R and T in the two-state (MWC) model (Monod et
al., 1965), are sufficient for most conditions, although the
addition of effectors such as 2,3-diphosphoglycerate
(DPG) or inositol hexakisphosphate (IHP) indicate that
additional states may be needed to completely describe
the system (Minton and Imai, 1974; Imai, 1982; Kister et
al., 1987a and b). Thus one problem is to determine
whether these effectors simply shift the equilibrium
between the original allosteric states (without effectors)
or change the intrinsic ligand affinity, implying the need
for additional allosteric states.
The separation of the allosteric and affinity effects
requires the determination of the affinities for the two
allosteric states, KR and KT, and the allosteric parameter
L which gives the equilibrium ratio T/R for the deoxy
form. The oxygenation curves for various effectors are
shown in Fig. 1. If two curves are parallel, they differ by a
change in the R- and T-state ligand affinities by the same
factor, with no change in L; this would be a pure affinity
effect. At the other extreme, if the two affinities remain
unchanged and L is different, then only the ligation level
for the transition point between the original two forms
changes; this would be a pure allosteric effect. As seen in
Fig. 1, addition of effectors to Hb results in shifts
involving a mixture of these two cases. Furthermore,
when the effector is so strong that the substates involved
(triply and fully liganded) are not fully in the R state,
then the observed upper asymptote no longer gives the
true R-state affinity.
The low affinity of the T-state is generally well deter-
mined from the equilibrium data. The three-dimensional
plot in Fig. 2 shows how sigma, the least squares differ-
ence between the data and simulation, depends on KT and
L. The bowl-shaped form shows a well-defined minimum,
within narrow limits of the two parameters. Deviations
from this minimum in any direction result in a rapidly
increasing error. A maximum value for sigma was used
which generates the plane cutting the plot.
The same plot for KR and L, Fig. 3, shows a broad
minimum in a valley of many possible solutions; there is a
compensation between the R-state affinity and L. This is
the most optimistic view, because values for the Hill plot
log[Y/(1 - Y)], rather than Y, were used to calculate
the error. This gives a much higher weight to the asymp-
totes which influence the value for the affinities. The
minimum was broader when Ywas used.
The situation is worse for the case of strong effectors, as
seen in Fig. 4; the valley of equally good solutions is much
larger and is not sensitive to the weighting method. There
is a family of solutions for KR and L with no upper limit on
these parameters, as reported by DiCera et al. (1987a).
R-State properties are difficult to determine because the
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FIGURE 1 Oxygen equilibrium curves of Hb in the presence of the
effectors indicated at pH 7.2, 250C. Other experimental conditions are
given in Table 1.
triply and fully liganded forms have a T-state contribu-
tion.
There are also experimental problems such as the
normalization factor (Marden et al., 1989) and the fact
that even under one atmosphere oxygen the sites are not
fully saturated. We conclude that the R-state affinity
cannot be deduced from the equilibrium curves, even
within a factor of 10 for many cases.
Kinetic measurements of the ligand on and off-rates
can provide an independent measure of the affinity. This
method still has some problems for oxygen due to an
incomplete ligand saturation with strong effectors. The
or
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FIGURE 3 Sigma (as in Fig. 2) as a function of log(KR) and log(L). The
broad minimum shows some compensation between the two parameters.
Variations were from 0.1 to I mmHg for KR (left to right) and from 3 to
7 for log(L), with KT - 25 mmHg. Sigma was calculated from the values
used to generate the Hill plot (log[Y/(I - Y)], Fig. 1), which weights
the asymptotes more heavily than using Y (fractional saturation) and
sharpens the minimum in sigma.
higher affinity of Hb for CO, by a factor of -250 relative
to oxygen, permits preparation of 100% saturated sam-
ples. In addition the R- and T-state on-rates are well
resolved for CO (factor of 30 as compared to a factor of 3
for oxygen); thus even if there are substantial amounts of
T state tetramers present, a clear R-state kinetic signal
can be observed. For these reasons, the kinetic parameters
were determined for CO.
In addition we made measurements to show that the
partition function for the two ligands is little changed by
the effectors. This allows the shift in the R-state affinity
due to the effector to be considered the same for oxygen
and CO. Using the affinity for the first ligand from the
equilibrium curves as for the T state, and the kinetically
determined affinity (for the fourth ligand) for the R state,
we can separate the affinity and allosteric contributions to
the shift in p50.
MATERIALS AND METHODS
Hb A was prepared from fresh red blood cell hemolysate by chromatog-
raphy on a DEAE-Sephadex column. Hb was diluted in a buffer
containing 100 mM NaCl and 50 mM bis Tris (Sigma Chemical Co., St.
Louis, MO) at pH 7.2, 25°C. Experiments in the absence of chloride
were made in 10 mM Hepes buffer adjusted with KOH to pH 7.2.
Because the addition of strong effectors may change the solution pH, the
FIGURE 2 Plot of sigma, the least squares error between the data and
simulation, as a function of log(KT) and log(L). Data are the oxygen
equilibrium curve for Hb at pH 7.2, 250C, 100 mM NaCl (second entry
in Table 1). Total variations were from 13 to 83 mmHg for KT (left to
right) and from 4.3 to 5.7 for log(L) (back to front) with KR - 0.3
mmHg. The bowl shape shows a well-defined minimum for the simula-
tions.
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L
FIGURE 4 Sigma as a function of log(KR) and log(L) for Hb with both
IHP and L35 as effectors. Variations were from 1 to 25 mmHg for KR
and from 5 to 9 for log(L) with KT - 300 mmHg. No minimum was
found. There is a family of solutions of KR and L.
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samples were adjusted to pH 7.2 after addition of the effector. Other
chemicals were bezafibrate from Boehringer Mannheim GmbH (Mann-
heim, FRG), potassium ferricyanide from E. Merck (Darmstadt, FRG),
DPG and IHP from Sigma Chemical Co. LR16 and L35' were gifts
from Dr. Lalezari (Lalezari et al., 1988) of the Montefiore Medical
Center (Bronx, NY).
Oxygen equilibrium measurements
Equilibrium curves were measured by a continuous method using a
Hemox analyzer (TCS-Medical Products Co., Huntingdon Valley, PA)
as previously described (Kister et al., 1987a). Simultaneous recordings
were made of the Po, with a Clark electrode and the light transmission at
560 nm in a 1-cm cuvette; typical samples were 60,M in heme.
Association rates by flash
photolysis
The recombination (on) rates were measured for both oxygen and CO
after photodissociation by a 10-ns pulse at 532 nm (Quantel YAG laser,
France). Samples were 0.1 mM in heme in 1-mm optical cuvettes, with
observation at 436 nm (Marden et al., 1988). Measurements were made
at 1 and 0.1 atm CO at different dissociation levels. The R-state
properties are best observed at low levels of dissociation (<10%) where
the main photoproduct is triply liganded tetramer, and at maximum
ligand concentration to minimize the extent of the R-to-T transition.
Dissociation rates
The CO off-rates were measured by the oxidation of HbCO by
ferricyanide (Antonini et al., 1965; Lanir et al., 1982) or by replacement
of CO by NO (Gray and Gibson, 1971; DeYoung et al., 1976). Hb
concentration was typically 0.3 mM in heme. The kinetics were recorded
using a Cary 219 spectrophotometer (Varian Associates, Inc., Palo Alto,
CA).
Oxidation by ferricyanide
Hb samples were first deoxygenated under argon and then equilibrated
with 0.1 or 1 atmosphere CO in tonometers attached to a cuvette of 2
mm optical pathlength. Injection of ferricyanide (1-12 mM final
concentration) resulted in a change in absorption at 568 nm from -0.9
OD for the CO form to 0.2 for the ferric Hb. One side effect is the
production of ferrocyanide which is known to bind to Hb and may
possibly interfere with the measurements (Antonini and Brunori, 1971).
Using CO recombination kinetics as a probe, we found that ferrocyanide
(formed by addition of Na-dithionite to ferricyanide) acts as an effector
like other negative ions (Shimizu and Bucci, 1974; Chiancone et al.,
1975). Measurements made in the presence of 100 mM NaCl showed no
difference for samples with and without ferrocyanide.
Replacement reaction with nitric oxide
Samples of Hb-CO (equilibrated with 0.1 atm CO) were injected into
1-cm cuvettes containing buffer equilibrated with I atm NO. The
kinetics were followed at 539 nm.
'Abbreviations used in this paper: bezafibrate (Bzf), 2-[4-[2[(4-chloro-
benzoyl)amino]ethyl]phenoxy]-2-methylproprionic acid; L35, 2-[4[3,5-
dichlorophenylureido)phenoxy]-2-methylpropionic acid; LR16, 2-[4-
(3,4-dichlorophenylureido)phenoxy]-2-methylpropionic acid.
Oxygen-CO partition coefficient
The change in partition coefficient was observed spectrophotometrical-
ly. Samples were prepared in a tonometer attached to an optical cuvette
with a 2-mm optical pathlength, and the absorbance spectrum was
recorded (Cary 219) between 700 and 500 nm.
A mixture of -50% oxygen and 50% CO bound Hb was prepared, and
effector was then added to see whether the spectrum shifts towards more
oxygen or CO form. For each effector (E) the experiment required six
spectra:
1. HbO2 6. E*HbO2
2. HbO2-CO -1-3. E*HbO2-CO
5. HbCO 4. E*HbCO.
A series of four spectra (arrows) were recorded on the same sample: (a)
1 atm oxygen without effector, (b) addition of CO gas which produces a
nearly equal mixture ofCO and oxy forms, (c) addition of effector, and
(d) reequilibration with 1 atm CO.
Independently, a sample was equilibrated with 1 atm oxygen and then
1 atm CO, so the pure CO spectrum (5) could be deduced from
spectrum 1 of each series. In addition, the same amount of effector was
added to samples under 1 atm oxygen (1) to obtain spectrum 6 to correct
for the minor absorbance changes due to the effectors (typically 0-3%
due to a red shift of the alpha peak). Spectra were analyzed at six
wavelengths (580, 577, 575, 565, 560, and 520 nm) for the percentage
oxygen or CO bound. Spectra 1 and 5 were used as references to
calculate the fraction HbO2 and HbCO for the mixture (2) without
effector; the spectra 3, 4, and 6 were used for the case with effectors.
RESULTS
Oxygen equilibrium
The oxygen equilibrium curves for several effectors are
shown in Fig. 1. All the effectors showed a shift to the
right on the Hill plot, implying a lower oxygen affinity. In
addition the transition to the high-affinity state occurs
later in the saturation curve, indicating a shift in allosteric
equilibrium toward the T state. The stronger effectors
show a smaller cooperativity and incomplete saturation,
even under one atmosphere of oxygen; in these cases it is
difficult to distinguish between an R-state asymptote of
lower affinity and an apparent shift due to a T-state
contribution in the liganded forms. However, the values
for p5O and KT can be accurately determined from the
equilibrium curves and are summarized in Table 1 and
Fig. 5.
Association rates
The bimolecular recombination kinetics of CO to Hb
after photodissociation were measured for each effector.
All the effectors caused a decrease in the on-rate of the
rapid (R-state) phase. The R-state kinetics were best
observed for low partial photolysis for samples equili-
brated with one atmosphere CO. Certain examples have
Marden et al. Effectors of Hemoglobinet al. Effectors of Hemoglobin 399
TABLE 1 Oxygen equilibrium parameters and CO
on-rates
Effector pS0 KT KR log(L) kR,.
mmHg mmHg mmHg 1lo M-' s'
None 1.9 4.8 0.2 3.8 12.0
Cl 5.4 25.0 0.3 4.9 7.0
DPG 15.0 66.0 0.6 5.5 3.5
Bzf 16.0 60.0 0.9 4.9 2.5
LR 16 19.5 62.0 1.1 4.9 2.0
DPG + Bzf 27.0 133.0 1.1 5.5 2.0
L35 46.0 150.0 1.3 6.0 1.8
IHP 78.0 166.0 2.2 6.0 1.5
IHP + Bzf 130.0 212.0 2.2 6.9 1.5
IHP + L35 138.0 210.0 1.8 7.4 1.8
Solution conditions were 50 mM Bis Tris, pH 7.2, 25°C (Kister et al,
1987). Effector concentrations were 100 mM (Cl), 0.5 mM (LR16 and
L35), 1 mM (DPG and IHP), and 5 mM for Bzf. Oxygen equilibrium
data were used to determine all values of p50 and KT, and the first two
entries for KR. The changes in R-state affinity with effectors were
calculated from the changes in the CO on- and off-rates.
been published previously (Marden et al., 1988). The
weakest effectors were Cl, DPG, and bezafibrate; the
strong effectors LR16, L35, and IHP showed two kinetic
components of nearly equal amplitude for the R state
differing in rate by about a factor of 2. This effect has
been reported for IHP (Gray and Gibson, 1971) and was
attributed to chain differences.
DPG
Cl Bzf Bzf
IHP
+
HkP 135
Dissociation rates
As previously observed (DeYoung et al., 1976), the
dissociation rates are pH dependent with a transition
centered near pH 7. As these off-rates are rather insensi-
tive to the effectors, slight changes in pH could produce
comparable changes in rate. Measurements were also
made near pH 8 to better observe differences due only to
the effectors.
Below pH 7.2 and in the presence of effectors, the
ferricyanide data shows kinetics which accelerate. This
could be related to the formation of a T-met state
(Kilmartin, 1973; Perutz et al., 1974). From the initial
rate of the oxidation process, the ferrous R-state rate is
involved. Within the experimental errors, the CO off-rate
shows little change upon addition of effectors, except for
IHP (a factor of 1.6 decrease). The rates calculated from
the kinetics of replacement of CO by NO were in agree-
ment with these relative changes.
Oxygen-CO partition coefficient
Effector was added to a sample of Hb with -50% CO and
50% oxygen bound; a shift toward the oxy or CO refer-
ence spectra would indicate that the partition is changed
by the effector. Corrections were made for dilution and
the small change in absorbance of the pure CO and oxy
forms due to the effector. The change in partition coeffi-
cient was small as previously reported for IHP (DiCera et
al., 1987b); IHP caused a 3% increase in the CO form,
whereas Bzf favored oxygen as ligand by a few percent.
Overall the results indicate that the effectors shift the
affinity of the liganded conformation of Hb for oxygen
and CO by nearly the same factor.
zcAJ
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FIGURE 5 Relative change in the ligand-binding parameters (logarith-
mic scale), with respect to stripped Hb. The total height of the column
represents the factor increase in p50 (50% saturation with oxygen). The
decrease in the R-state CO on-rate (measured at low partial photolysis,
1 atm CO) is given by the sum of two lower segments. The lowest
segment shows the increase in the CO off-rate for the liganded (R)
form.
DISCUSSION
The separation of the allosteric and affinity factors
requires values for the R- and T-state affinities. The
R-state affinity is difficult to determine from the equilib-
rium data, especially in the presence of strong effectors
which lower the ligand affinity and favor the deoxy
allosteric state. Properties of the ligated allosteric state
will be masked if the tetramers exist as an appreciable
fraction ofT state with three or four ligands bound. There
cannot be much precision in values of the liganded
parameters if the experimental conditions do not achieve
full saturation or a full transition to the R state.
Because the affinity for the fourth ligand is poorly
determined from oxygen equilibrium data, we have mea-
sured the on- and off-rates for CO to estimate changes in
this value. The off-rates show little dependence on the
effector. The on-rate for CO (and for oxygen) decreases
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by as much as a factor of 8. Overall there is a decrease in
the R-state affinity for CO by nearly a factor of 10.
The lack of a significant change in the partition coeffi-
cient was unexpected, because oxygen and CO show a
different dependence on the kinetic parameters. The large
difference in affinity for the R and T states (factor of 100
at pH 7.2 with 100 mM NaCI) is due predominantly to
the off-rates for oxygen, whereas this factor is mainly
accounted for by the on-rates for CO (Gray and Gibson,
1971; Murray et al., 1988). The small changes in the
partition coefficient permit use of the CO data to estimate
the corresponding shift in affinity for oxygen.
Classification of the effectors
From oxygen equilibrium results, the partial pressure of
oxygen to obtain 50% saturation (p50) can be used to
estimate the relative strength of the various effectors.
This is complicated by the fact that different concentra-
tions of effectors were used: some show a clear plateau of
p50 vs. effector concentration (DPG, IHP), whereas
others (LR16 and L35) reached the solubility limit before
the plateau was obtained. A general classification in order
of increasing p50 (Table 1) for oxygen equilibrium data
would be: Cl < DPG < Bzf < LR16 < L35 < IHP.
Because the binding site for Bzf, LR16, and L35 is
different from the DPG (IHP) site (Perutz et al., 1986;
Lalezari et al., 1989), effectors can be bound at each site
and the observed difference is larger than for either
effector alone. The relative change in p50 is shown in Fig.
5; the horizontal axis is a list of effectors in order of
increasing p50.
The ligand on-rates provide an additional measure of
the relative effector strength and confirm this scheme.
The on-rate and p50 do not show the same factor of
change for the different effectors. For example the CO
on-rate has little additional change beyond the value for
LR16, and practically no change for the combination
IHP + Bzf relative to IHP alone; however, the p50 value
for oxygen equilibrium still shows large changes between
LR16 and IHP or between IHP and IHP + Bzf (Fig. 5,
values are normalized to that for Hb without effectors).
Substate populations
The allosteric transition in Hb results in a small equilib-
rium population (<10%) of the partially liganded forms.
With a nonallosteric tetramer, 37% of the tetramers
would be in the doubly liganded form at 50% ligand
saturation. With strong effectors, the transition occurs at
a higher ligation level and the doubly liganded population
is greatly enhanced (to >30% in the case of IHP + L35),
approaching that of a nonallosteric system. However, the
sharp transition near full ligand saturation still maintains
a low population of triply liganded forms.
The validity of the kinetic method to determine the
equilibrium affinity for the R state requires some discus-
sion. One fundamental problem may arise due to differ-
ences between the alpha- and beta-chains (Olson and
Gibson, 1971; Mansouri and Winterhalter, 1973). If the
fourth ligand is more likely to bind to one type of chain,
and the quantum yield for the bimolecular phase in flash
photolysis experiments is higher for the other type of
chain, then it is possible that equilibrium and kinetic
studies could be made on two different tetrameric forms.
The kinetic results show a single R-state rate for the weak
effectors (Cl, DPG, Bzf), indicating that the two chains
have the same rate. Strong effectors like IHP show two
R-state rates; we have used the faster rate for the
calculation of the R-state affinity.
A second question concerns protein relaxation. After
photolysis there is a relaxation to a mixture of R and T
substates. The R and T on-rates are easily separable for
CO recombination. Thus unlike equilibrium measure-
ments which show an averaged asymptote, the kinetic
data show resolved R and T signals. Furthermore because
the initial state is fully liganded R4, there might be a
difference in rebinding to the photoproduct R3* (which is
still in the R4 conformation) and to rebinding to stable R3
after relaxation to the R3-T3 equilibrium mixture.
520 540 560
X (nm)
580
FIGURE 6 Test for the change by the effector in the oxygen, CO
partition coefficient at pH 7.1, 25°C. To a sample under I atm oxygen
(spectrum 1), a volume of CO gas is added to obtain approximately a
50:50 mixture of HbO2 and HbCO (2). Effectors (lHP and Bzf in this
example) are then added (3), before final equilibration under 1 atm CO
(4). The small difference between spectra 2 and 3 indicates little change
in the partition coefficient due to the effector.
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Although no differences have been demonstrated, we
emphasize that the kinetically determined affinity refers
to binding of the fourth ligand to the fully liganded
conformation.
Allosteric vs. affinity factors
From the equilibrium data for the oxygen affinity of the
first ligand (T state) and the kinetically determined
values for the fourth ligand affinity (R state), the shift in
p50 due to the change in affinities can be estimated by
recalculating the equilibrium curve using a two-state
model. Suppose there is a transition from the curve
without effectors (KR, KT, L) to (K'R, KT, L') for the case
with effector. We can generate an intermediate curve
(K'R, KT, L) to determine the shift in p5O relative to (KR,
KT, L) due to the affinity factors. The remaining shift is
attributed to the allosteric parameters. Similarly a curve
can be calculated with the original affinities (without
effector) and L' (with effector) to estimate the allosteric
contribution. The results are represented graphically in
Fig. 7, where the allosteric and affinity contributions are
separated for the change in p5O. Errors in the R-state
affinity are the more critical, as values of p5O are nearly
linear with KR.
The results indicate that the changes in the affinities
play the larger role in the shift in p5O. For example, DPG
shifts p5O by a factor of 7.4 relative to Hb without
effectors; the contribution due to the change in affinities
is approximately a factor of 3.2, or 57% of the total. The
DPG
+
Cl Bzf Bzf
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FIGURE 8 Relative contribution of affinity and allosteric factors (as in
Fig. 7) for the shift in p50 (total height) due to a change in pH (Lee et
al., 1988). Values at pH 7.4 were taken as reference. The transition
above pH 7.4 is essentially allosteric in nature, whereas at acid pH the
transition is mainly due to the affinity factors.
large affinity contribution is not surprising, because p5O
is an average affinity limited between the pure R and T
affinities. For a purely allosteric effect, the upper limit for
p5O is KT, which is nearly attained when IHP is present.
Based on simulation of the data for stripped Hb, p5O
could increase at most by a factor of 5. The observed
changes in p5O for the series of effectors are therefore due
in large part to the shift in the affinities.
There is a potential problem in calling a state R or T.
Both the R- and T-state affinities vary by over a factor of
10 for the different effectors, yet the R-state affinity for
Hb with IHP differs from the T-state affinity for Hb
without effectors by less than a factor of 2. For each
effector, one can discuss a transition from R' to T' which
can still be described by a two-state model, yet there is no
guarantee that all the "R" states will satisfy other crite-
ria, whether crystallographic or spectroscopic, as clearly
being an R state.
The same analysis can be applied to the equilibrium
curves vs. pH (Lee et al., 1988). Extracting all parame-
ters from the equilibrium data, we found that there were
two regions (Fig. 8). Above pH 7.4 there is little change in
KR and the shift in p5O is mainly allosteric. At low pH the
change is due to the affinity factors. The equilibrium
results are in agreement with kinetic studies (DeYoung et
al., 1976), which show that the rates for the fourth ligand
are nearly constant above this critical pH.
CONCLUSIONS
Effectors change the allosteric equilibrium and ligand
affinity of both allosteric states. In general a new allo-
steric state must be considered for each effector and each
combination of effectors. Considering p5O as an indicator
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FIGURE 7 Relative contribution of affinity (hatched region) and allo-
steric parameters (open region) toward the shift of p50 for the effectors
indicated (see Table 1 for experimental conditions). The total height
represents the factor change in p50 relative to Hb without effectors (as
in Fig. 5).
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of effector strength, the affinity parameters cause a larger
shift than the allosteric factors.
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